$CLIR
ClearSign Technologies Corp

2021 Q4 Form 10-K Financial Statement

#000155837022004842 Filed on March 31, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021
Revenue $54.00K $190.0K $607.0K
YoY Change
Cost Of Revenue $51.00K $278.0K $1.059M
YoY Change -79.6% 54.44% 279.57%
Gross Profit $3.000K -$88.00K -$452.0K
YoY Change -101.19% -51.11% 62.01%
Gross Profit Margin 5.56% -46.32% -74.46%
Selling, General & Admin $984.0K $1.131M $5.013M
YoY Change -15.9% -0.79% 8.51%
% of Gross Profit 32800.0%
Research & Development $244.0K $1.138M $2.680M
YoY Change -44.55% 214.36% 32.08%
% of Gross Profit 8133.33%
Depreciation & Amortization $45.00K $123.0K $260.0K
YoY Change -10.0% 146.0% 23.81%
% of Gross Profit 1500.0%
Operating Expenses $1.228M $2.269M $7.693M
YoY Change -23.44% 51.57% 15.63%
Operating Profit -$1.225M -$2.357M -$8.145M
YoY Change -34.0% 40.55% 17.5%
Interest Expense $1.000K $0.00 $1.000K
YoY Change
% of Operating Profit
Other Income/Expense, Net $248.0K $4.000K $252.0K
YoY Change 530.0%
Pretax Income -$1.227M -$2.353M -$7.892M
YoY Change -34.03% 40.06% 14.54%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.227M -$2.353M -$7.891M
YoY Change -33.82% 40.31% 14.63%
Net Earnings / Revenue -2272.22% -1238.42% -1300.0%
Basic Earnings Per Share -$0.04 -$0.07 -$0.25
Diluted Earnings Per Share -$38.86K -$0.07 -$252.7K
COMMON SHARES
Basic Shares Outstanding 31.57M 31.49M 31.23M
Diluted Shares Outstanding 31.49M 31.23M

Balance Sheet

Concept 2021 Q4 2021 Q3 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.607M $8.841M $7.607M
YoY Change -13.75% -16.99% -13.75%
Cash & Equivalents $7.607M $8.841M $7.607M
Short-Term Investments
Other Short-Term Assets $345.0K $65.00K $345.0K
YoY Change 74.24% -90.44% -38.39%
Inventory
Prepaid Expenses $345.0K $390.0K
Receivables $33.00K $0.00 $72.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $8.024M $9.296M $8.024M
YoY Change -14.47% -17.88% -14.46%
LONG-TERM ASSETS
Property, Plant & Equipment $530.0K $657.0K $530.0K
YoY Change 24.12% 39.79% 23.26%
Goodwill
YoY Change
Intangibles $799.0K $942.0K
YoY Change -38.63%
Long-Term Investments
YoY Change
Other Assets $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $1.339M $1.609M $1.339M
YoY Change -23.0% -10.61% -23.05%
TOTAL ASSETS
Total Short-Term Assets $8.024M $9.296M $8.024M
Total Long-Term Assets $1.339M $1.609M $1.339M
Total Assets $9.363M $10.91M $9.363M
YoY Change -15.81% -16.88% -15.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $224.0K $274.0K $224.0K
YoY Change -48.51% -68.86% -49.09%
Accrued Expenses $218.0K $606.0K $423.0K
YoY Change -42.93% -10.88% -23.09%
Deferred Revenue $84.00K $0.00
YoY Change -10.64%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $731.0K $1.082M $731.0K
YoY Change -32.31% -32.8% -32.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $350.0K $403.0K $350.0K
YoY Change 40.0% 38.97% 40.0%
Total Long-Term Liabilities $350.0K $0.00 $350.0K
YoY Change 39.44% -100.0% -30.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $731.0K $1.082M $731.0K
Total Long-Term Liabilities $350.0K $0.00 $350.0K
Total Liabilities $1.081M $1.485M $1.081M
YoY Change -31.58% -30.93% -31.58%
SHAREHOLDERS EQUITY
Retained Earnings -$82.77M -$81.54M
YoY Change 10.54%
Common Stock $3.000K $3.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.282M $9.420M $8.282M
YoY Change
Total Liabilities & Shareholders Equity $9.363M $10.91M $9.363M
YoY Change -15.81% -16.88% -15.8%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021
OPERATING ACTIVITIES
Net Income -$1.227M -$2.353M -$7.891M
YoY Change -33.82% 40.31% 14.63%
Depreciation, Depletion And Amortization $45.00K $123.0K $260.0K
YoY Change -10.0% 146.0% 23.81%
Cash From Operating Activities -$1.165M -$1.868M -$6.707M
YoY Change -35.99% 69.82% 12.46%
INVESTING ACTIVITIES
Capital Expenditures -$78.00K -$41.00K $73.00K
YoY Change 160.0% 2.5% 329.41%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$78.00K -$41.00K -$213.0K
YoY Change 160.0% 2.5% 9.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 108.0K 5.694M
YoY Change -100.0% -98.24% -11.45%
NET CHANGE
Cash From Operating Activities -1.165M -1.868M -6.707M
Cash From Investing Activities -78.00K -41.00K -213.0K
Cash From Financing Activities 0.000 108.0K 5.694M
Net Change In Cash -1.243M -1.801M -1.217M
YoY Change -31.33% -136.16% -547.43%
FREE CASH FLOW
Cash From Operating Activities -$1.165M -$1.868M -$6.707M
Capital Expenditures -$78.00K -$41.00K $73.00K
Free Cash Flow -$1.087M -$1.827M -$6.780M
YoY Change -39.27% 72.36% 13.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Auditor Location
AuditorLocation
Santa Monica, California
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31581666
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30077436
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001434524
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-35521
CY2021 dei Entity Registrant Name
EntityRegistrantName
CLEARSIGN TECHNOLOGIES CORP
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2056298
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
8023 East 63rd Place, Suite 101
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Tulsa
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
74133
CY2021 dei City Area Code
CityAreaCode
206
CY2021 dei Local Phone Number
LocalPhoneNumber
673-4848
CY2021 dei Security12b Title
Security12bTitle
Common Stock
CY2021 dei Trading Symbol
TradingSymbol
CLIR
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q2 dei Entity Public Float
EntityPublicFloat
120917861
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32150996
CY2021 dei Auditor Firm
AuditorFirmId
207
CY2020 dei Auditor Firm
AuditorFirmId
285
CY2021 dei Auditor Name
AuditorName
BPM LLP
CY2021 dei Auditor Location
AuditorLocation
Santa Monica, California
CY2020 dei Auditor Name
AuditorName
Gumbiner Savett Inc.
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7607000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11121000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
607000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2020Q4 us-gaap Assets Current
AssetsCurrent
9382000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
530000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
799000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8824000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91035000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
84411000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
9000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
39000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
92000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
345000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
466000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
8024000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1302000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10000
CY2021Q4 us-gaap Assets
Assets
9363000
CY2020Q4 us-gaap Assets
Assets
11121000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
224000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
435000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
205000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
169000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
218000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
382000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
94000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
731000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1080000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
350000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
249000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
251000
CY2021Q4 us-gaap Liabilities
Liabilities
1081000
CY2020Q4 us-gaap Liabilities
Liabilities
1580000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31581666
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30077436
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82765000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74874000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
8282000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
9540000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
1000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8282000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9541000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9363000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1059000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
279000
CY2021 us-gaap Gross Profit
GrossProfit
-452000
CY2020 us-gaap Gross Profit
GrossProfit
-279000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2680000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2029000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5013000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4624000
CY2021 us-gaap Operating Expenses
OperatingExpenses
7693000
CY2020 us-gaap Operating Expenses
OperatingExpenses
6653000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-8145000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-6932000
CY2021 us-gaap Other Income
OtherIncome
252000
CY2020 us-gaap Other Income
OtherIncome
44000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
CY2021 us-gaap Profit Loss
ProfitLoss
-7892000
CY2020 us-gaap Profit Loss
ProfitLoss
-6886000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7891000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-6884000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31230806
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27837095
CY2021 us-gaap Profit Loss
ProfitLoss
-7892000
CY2020 us-gaap Profit Loss
ProfitLoss
-6886000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7883000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6886000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9541000
CY2021 clir Shares Issued Through Use Of At Market Issuance
SharesIssuedThroughUseOfAtMarketIssuance
5309000
CY2021 clir Common Stock Issued For Exercise Of Options3.80 Per Share
CommonStockIssuedForExerciseOfOptions3.80PerShare
3.80
CY2021 clir Stock Issued During Period Value Stock Options Exercised3.80 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised3.80PerShare
36000
CY2021 clir Common Stock Issued For Exercise Of Options3.10 Per Share
CommonStockIssuedForExerciseOfOptions3.10PerShare
3.10
CY2021 clir Stock Issued During Period Value Stock Options Exercised3.10 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised3.10PerShare
54000
CY2021 clir Common Stock Issued For Exercise Of Options2.93 Per Share
CommonStockIssuedForExerciseOfOptions2.93PerShare
2.93
CY2021 clir Stock Issued During Period Value Stock Options Exercised2.93 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised2.93PerShare
0
CY2021 clir Common Stock Issued For Exercise Of Options1.90 Per Share
CommonStockIssuedForExerciseOfOptions1.90PerShare
1.90
CY2021 clir Stock Issued During Period Value Stock Options Exercised1.90 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.90PerShare
12000
CY2021 clir Common Stock Issued For Exercise Of Options1.85 Per Share
CommonStockIssuedForExerciseOfOptions1.85PerShare
1.85
CY2021 clir Stock Issued During Period Value Stock Options Exercised1.85 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.85PerShare
6000
CY2021 clir Common Stock Issued For Exercise Of Options1.21 Per Share
CommonStockIssuedForExerciseOfOptions1.21PerShare
1.21
CY2021 clir Stock Issued During Period Value Stock Options Exercised1.21 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.21PerShare
155000
CY2021 clir Common Stock Issued For Exercise Of Options0.98 Per Share
CommonStockIssuedForExerciseOfOptions0.98PerShare
0.98
CY2021 clir Stock Issued During Period Value Stock Options Exercised0.98 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised0.98PerShare
0
CY2021 clir Common Stock Issued For Exercise Of Options0.89 Per Share
CommonStockIssuedForExerciseOfOptions0.89PerShare
0.89
CY2021 clir Stock Issued During Period Value Stock Options Exercised0.89 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised0.89PerShare
55000
CY2021 clir Common Stock Issued For Exercise Of Warrants1.80 Per Share
CommonStockIssuedForExerciseOfWarrants1.80PerShare
1.80
CY2021 clir Shares Issued Upon Exercise Of Warrants
SharesIssuedUponExerciseOfWarrants
67000
CY2021 clir Common Stock For Services Per Share Issue Two
CommonStockForServicesPerShareIssueTwo
2.33
CY2021 clir Shares Issued For Services2.33 Per Share
SharesIssuedForServices2.33PerShare
26000
CY2021 clir Common Stock For Services Per Share Issue One
CommonStockForServicesPerShareIssueOne
1.93
CY2021 clir Shares Issued For Services1.93 Per Share
SharesIssuedForServices1.93PerShare
7000
CY2021 clir Stockissued During Period Valuein Payment Of Accrued Compensation
StockissuedDuringPeriodValueinPaymentOfAccruedCompensation
217000
CY2021 clir Adjustments To Additional Paid In Capital Share Based Payment Arrangement Option Increase For Cost Recognition Two
AdjustmentsToAdditionalPaidInCapitalShareBasedPaymentArrangementOptionIncreaseForCostRecognitionTwo
262000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
418000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9000
CY2021 us-gaap Profit Loss
ProfitLoss
-7892000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8282000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9226000
CY2020Q4 clir Shares Issued Offering Price Per Share
SharesIssuedOfferingPricePerShare
2.00
CY2020 clir Stock Issued During Period Value Secondary Offering
StockIssuedDuringPeriodValueSecondaryOffering
6053000
CY2020 clir Common Stock For Services Per Share Issue Two
CommonStockForServicesPerShareIssueTwo
2.33
CY2020 clir Shares Issued For Services2.33 Per Share
SharesIssuedForServices2.33PerShare
9000
CY2020 clir Common Stock For Services Per Share Issue Three
CommonStockForServicesPerShareIssueThree
1.03
CY2020 clir Shares Issued For Services1.03 Per Share
SharesIssuedForServices1.03PerShare
8000
CY2020 clir Common Stock Issued For Exercise Of Options1.90 Per Share
CommonStockIssuedForExerciseOfOptions1.90PerShare
1.90
CY2020 clir Stock Issued During Period Value Stock Options Exercised1.90 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.90PerShare
33000
CY2020 clir Common Stock Issued For Exercise Of Options0.89 Per Share
CommonStockIssuedForExerciseOfOptions0.89PerShare
0.89
CY2020 clir Stock Issued During Period Value Stock Options Exercised0.89 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised0.89PerShare
17000
CY2020 clir Common Stock Issued For Exercise Of Options1.00 Per Share
CommonStockIssuedForExerciseOfOptions1.00PerShare
1.00
CY2020 clir Stock Issued During Period Value Stock Options Exercised1.00 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised1.00PerShare
65000
CY2020 clir Common Stock Issued For Exercise Of Options0.72 Per Share
CommonStockIssuedForExerciseOfOptions0.72PerShare
0.72
CY2020 clir Stock Issued During Period Value Stock Options Exercised0.72 Per Share
StockIssuedDuringPeriodValueStockOptionsExercised0.72PerShare
11000
CY2020 clir Stockissued During Period Valuein Payment Of Accrued Compensation
StockissuedDuringPeriodValueinPaymentOfAccruedCompensation
407000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
264000
CY2020 clir Adjustments To Additional Paid In Capital Share Based Payment Arrangement Option Increase For Cost Recognition Two
AdjustmentsToAdditionalPaidInCapitalShareBasedPaymentArrangementOptionIncreaseForCostRecognitionTwo
334000
CY2020 us-gaap Profit Loss
ProfitLoss
-6886000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9541000
CY2021 us-gaap Profit Loss
ProfitLoss
-7892000
CY2020 us-gaap Profit Loss
ProfitLoss
-6886000
CY2021 clir Common Stock Issued For Services
CommonStockIssuedForServices
33000
CY2020 clir Common Stock Issued For Services
CommonStockIssuedForServices
17000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
680000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
800000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
260000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
210000
CY2021 us-gaap Exploration Abandonment And Impairment Expense
ExplorationAbandonmentAndImpairmentExpense
484000
CY2021 clir Gain On Forgiveness Of Payroll Protection Plan Loan
GainOnForgivenessOfPayrollProtectionPlanLoan
-251000
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-53000
CY2020 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
53000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-121000
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
75000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-205000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-382000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
53000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
361000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-10000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
44000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6707000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5964000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
73000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
140000
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
177000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-213000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-194000
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5309000
CY2020 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
6053000
CY2021 clir Proceeds From Exercise Of Stock Options
ProceedsFromExerciseOfStockOptions
385000
CY2020 clir Proceeds From Exercise Of Stock Options
ProceedsFromExerciseOfStockOptions
126000
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
251000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5694000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6430000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1217000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
272000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8824000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8552000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7607000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8824000
CY2021Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
217000
CY2020Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
205000
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4800000
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1300000
CY2020 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3242000
CY2020Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
2.00
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82800000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
418000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
257000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
242000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.058
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2021 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021Q4 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
77000
CY2020Q4 clir Property Plant And Equipment Excluding Lessor Asset Under Operating Lease And Construction In Progress After Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAndConstructionInProgressAfterAccumulatedDepreciation
43000
CY2021Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
453000
CY2020Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
384000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3076000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2777000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
530000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427000
CY2021 us-gaap Depreciation
Depreciation
38000
CY2020 us-gaap Depreciation
Depreciation
54000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
453000
CY2021 clir Funds Received
FundsReceived
44000
CY2020 clir Funds Received
FundsReceived
40000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
384000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
205000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
169000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
350000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
249000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
555000
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
722000
CY2020Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
720000
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
218000
CY2020Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
180000
CY2021Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
192000
CY2020Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
149000
CY2021Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
1132000
CY2020Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Before Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation
1049000
CY2021Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
1055000
CY2020Q4 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
1017000
CY2020Q4 clir Construction In Progress Net
ConstructionInProgressNet
11000
CY2021 us-gaap Payments For Rent
PaymentsForRent
218000
CY2020 us-gaap Payments For Rent
PaymentsForRent
215000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
320000
CY2021 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
63000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
63000
CY2021Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1016000
CY2020Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1614000
CY2021Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
97000
CY2020Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
128000
CY2021Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2020Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
8000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1121000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1750000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
322000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
448000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
799000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1302000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
117000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
96000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
74000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
42000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
9000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
11000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
349000
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
96000
CY2020Q4 clir Deferred Tax Assets Prepaid Income Expenses
DeferredTaxAssetsPrepaidIncomeExpenses
20000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-10000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-10000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
16388000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
14830000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
607000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1059000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
279000
CY2021 clir Cost Of Goods Sold Estimated Loss Upon Completion
CostOfGoodsSoldEstimatedLossUponCompletion
433000
CY2021Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
712000
CY2021 clir Cost Of Goods Sold Warranty Adjustment
CostOfGoodsSoldWarrantyAdjustment
86000
CY2020Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
450000
us-gaap Contract With Customer Asset Change In Method Credit Loss Expense Reversal
ContractWithCustomerAssetChangeInMethodCreditLossExpenseReversal
171000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
39000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
92000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
94000
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
96000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
257000
CY2020 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
10000
CY2021 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
10000
CY2021 clir Standard Product Warranty Accrual Adjustments And Other
StandardProductWarrantyAccrualAdjustmentsAndOther
-86000
CY2020 clir Standard Product Warranty Accrual Adjustments And Other
StandardProductWarrantyAccrualAdjustmentsAndOther
-171000
CY2021Q4 clir Net Operating Losses For Tax Purposes
NetOperatingLossesForTaxPurposes
76403000
CY2021 clir Operating Loss Carry Forward Estimated Limitation
OperatingLossCarryForwardEstimatedLimitation
686000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1657000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1446000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1558000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1325000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
99000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
121000
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
0
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
0
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
16388000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
14830000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16044000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14620000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
22000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
90000
CY2021Q4 clir Deferred Tax Liabilities Tax Deferred Expense Compensation And Benefits Sharebased Compensation Cost
DeferredTaxLiabilitiesTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCost
-263000
CY2020Q4 clir Deferred Tax Liabilities Tax Deferred Expense Compensation And Benefits Sharebased Compensation Cost
DeferredTaxLiabilitiesTaxDeferredExpenseCompensationAndBenefitsSharebasedCompensationCost
-120000
CY2021Q4 clir Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
26000
CY2020Q4 clir Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
-10000
CY2021Q4 clir Deferred Tax Assets Prepaid Income Expenses
DeferredTaxAssetsPrepaidIncomeExpenses
43000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16388000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14830000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2020Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
62500000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000.0
CY2019Q4 clir Ownership Percentage Of Noncontrolling Interest Increase From Amount Granted As Compensation
OwnershipPercentageOfNoncontrollingInterestIncreaseFromAmountGrantedAsCompensation
1
CY2021 clir Noncontrolling Interest Increase From Stock Awards
NoncontrollingInterestIncreaseFromStockAwards
0
CY2020 clir Noncontrolling Interest Increase From Stock Awards
NoncontrollingInterestIncreaseFromStockAwards
1000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y11M23D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.9189
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.7650
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0059
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0126
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2697000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.18
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M10D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2131000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.53
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y11M26D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1065000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.15
CY2021 clir Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P8Y4M24D
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
743000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.07
CY2020 clir Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y2M23D
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
327000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.41
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
117000
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.08
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
471000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.70
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
60000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.88
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2964000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.06
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M20D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2697000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.18
CY2020 clir Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3
P7Y6M10D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2178000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.72
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y2M12D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2380000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.26
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y5M23D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
513000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1725000
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
80000
CY2020Q4 clir Class Of Warrant Or Right Weighted Average Exercise Price Outstanding
ClassOfWarrantOrRightWeightedAverageExercisePriceOutstanding
1.80
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
80000
CY2019Q4 clir Class Of Warrant Or Right Weighted Average Exercise Price Outstanding
ClassOfWarrantOrRightWeightedAverageExercisePriceOutstanding
1.80
CY2021 clir Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
38000
CY2021 clir Class Of Warrant Or Right Weighted Average Exercise Price Exercised
ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
1.80
CY2020 clir Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0
CY2021 clir Class Of Warrant Or Right Forfeited Or Expired
ClassOfWarrantOrRightForfeitedOrExpired
43000
CY2021 clir Class Of Warrant Or Right Weighted Average Exercise Price Forfeited Or Expired
ClassOfWarrantOrRightWeightedAverageExercisePriceForfeitedOrExpired
1.80
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
80000
CY2020Q4 clir Class Of Warrant Or Right Weighted Average Exercise Price Outstanding
ClassOfWarrantOrRightWeightedAverageExercisePriceOutstanding
1.80
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
43000
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
51000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
363000
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
190000
CY2021Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
54000
CY2021Q1 us-gaap Gross Profit
GrossProfit
138000
CY2021Q3 us-gaap Gross Profit
GrossProfit
-88000
CY2021Q4 us-gaap Gross Profit
GrossProfit
3000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
2159000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
2037000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
2269000
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
1228000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2021000
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2021Q2 us-gaap Gross Profit
GrossProfit
-505000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2290000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2353000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1227000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2020Q2 us-gaap Gross Profit
GrossProfit
153000
CY2020Q3 us-gaap Gross Profit
GrossProfit
-180000
CY2020Q4 us-gaap Gross Profit
GrossProfit
-252000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
1963000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
1589000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
1497000
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
1604000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1963000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1390000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1677000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-1854000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06

Files In Submission

Name View Source Status
0001558370-22-004842-index-headers.html Edgar Link pending
0001558370-22-004842-index.html Edgar Link pending
0001558370-22-004842.txt Edgar Link pending
0001558370-22-004842-xbrl.zip Edgar Link pending
clir-20211231.xsd Edgar Link pending
clir-20211231x10k.htm Edgar Link pending
clir-20211231x10k001.jpg Edgar Link pending
clir-20211231x10k002.jpg Edgar Link pending
clir-20211231x10k003.jpg Edgar Link pending
clir-20211231x10k_htm.xml Edgar Link completed
clir-20211231xex10d13.htm Edgar Link pending
clir-20211231xex10d14.htm Edgar Link pending
clir-20211231xex10d15.htm Edgar Link pending
clir-20211231xex10d18.htm Edgar Link pending
clir-20211231xex10d18001.jpg Edgar Link pending
clir-20211231xex10d18002.jpg Edgar Link pending
clir-20211231xex10d18003.jpg Edgar Link pending
clir-20211231xex10d18005.jpg Edgar Link pending
clir-20211231xex10d18008.jpg Edgar Link pending
clir-20211231xex10d18015.jpg Edgar Link pending
clir-20211231xex10d18020.jpg Edgar Link pending
clir-20211231xex10d18021.jpg Edgar Link pending
clir-20211231xex10d18022.jpg Edgar Link pending
clir-20211231xex10d18023.jpg Edgar Link pending
clir-20211231xex10d18024.jpg Edgar Link pending
clir-20211231xex10d18025.jpg Edgar Link pending
clir-20211231xex10d18026.jpg Edgar Link pending
clir-20211231xex10d18027.jpg Edgar Link pending
clir-20211231xex10d18028.jpg Edgar Link pending
clir-20211231xex10d18029.jpg Edgar Link pending
clir-20211231xex10d18030.jpg Edgar Link pending
clir-20211231xex10d18031.jpg Edgar Link pending
clir-20211231xex10d18032.jpg Edgar Link pending
clir-20211231xex10d18033.jpg Edgar Link pending
clir-20211231xex10d18034.jpg Edgar Link pending
clir-20211231xex10d18035.jpg Edgar Link pending
clir-20211231xex10d18039.jpg Edgar Link pending
clir-20211231xex10d19.htm Edgar Link pending
clir-20211231xex10d19001.jpg Edgar Link pending
clir-20211231xex10d19003.jpg Edgar Link pending
clir-20211231xex10d19004.jpg Edgar Link pending
clir-20211231xex10d19005.jpg Edgar Link pending
clir-20211231xex10d20.htm Edgar Link pending
clir-20211231xex10d20001.jpg Edgar Link pending
clir-20211231xex10d20002.jpg Edgar Link pending
clir-20211231xex10d20003.jpg Edgar Link pending
clir-20211231xex10d20004.jpg Edgar Link pending
clir-20211231xex10d20005.jpg Edgar Link pending
clir-20211231xex10d20006.jpg Edgar Link pending
clir-20211231xex10d20007.jpg Edgar Link pending
clir-20211231xex10d20008.jpg Edgar Link pending
clir-20211231xex23d1.htm Edgar Link pending
clir-20211231xex23d1001.jpg Edgar Link pending
clir-20211231xex23d2.htm Edgar Link pending
clir-20211231xex23d2001.jpg Edgar Link pending
clir-20211231xex31d1.htm Edgar Link pending
clir-20211231xex31d2.htm Edgar Link pending
clir-20211231xex32d1.htm Edgar Link pending
clir-20211231_cal.xml Edgar Link unprocessable
clir-20211231_def.xml Edgar Link unprocessable
clir-20211231_lab.xml Edgar Link unprocessable
clir-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending